Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5177-5186

  Chan, William F N ^a   Razavy, Haide ^a   Luo, Bin ^a   Shapiro, A M James ^a   Anderson, Colin C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; BUSULFAN; RAPAMYCIN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; CROSS REACTION; DONOR; FEMALE; GENETIC RESISTANCE; GRAFT RECIPIENT; GRAFT REJECTION; HEMATOPOIETIC CELL; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; ISOGRAFT; MOUSE; NONHUMAN; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; NONOBESE DIABETIC MOUSE; ORGAN DONOR; PRIORITY JOURNAL; RECESSIVE GENE; SKIN TRANSPLANTATION; SPLIT TOLERANCE; T LYMPHOCYTE; TISSUE SPECIFICITY; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; DBA MOUSE; HISTOCOMPATIBILITY; IMMUNOLOGY; METABOLISM; PANCREAS ISLET TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; IMMUNE TOLERANCE; ISLETS OF LANGERHANS TRANSPLANTATION; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED NOD; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

EID: 45949111602     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5177     Document Type: Article

References (63)

1. Owen, R. D. 1945. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102: 400-401.
2. Billingham, R- E., L. Brent, and P. B. Medawar. 1953. "Actively acquired tolerance" of foreign cells. Nature 172: 603-606.
3. Starzl, T. E., and R. M. Zinkernagel. 2001. Transplantation tolerance from a historical perspective. Nat. Rev. Immunol. 1: 233-239.
4. Cosimi, A. B., and D. H. Sachs. 2004. Mixed chimerism and transplantation tolerance. Transplantation 77: 943-946.
5. Anderson, C. C. 2004. Conceptual models in immunity/tolerance: application to transplantation. In Immunobiology of Organ Transplantation. D. S. Wilkes and W. J. Burlingham, eds. Kluwer/Plenum, New York, pp. 171-190.
6. Billingham, R. E., and L. Brent. 1959. Quantitative studies on tissue transplantation immunity: IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease. Phil. Trans. R. Soc. London 242: 439-477.
7. Billingham, R. E., and W. K. Silvers. 1962. Some factors that determine the ability of cellular inocula to induce tolerance of tissue homografts. J. Cell. Comp. Physiol. 60: 183-200.
8. Brent, L., and T. H. Courtenay. 1962. On the induction of split tolerance. In Mechanisms of tolerance. M. Hasek, A. Lengerova, and M. Vojtiskova, eds. Czech. Acadacemy of Science, Prague, p. 113.
9. Emery, D., and P. McCullagh. 1980. Immunological reactivity between chimeric cattle twins: I. Homograft reaction. Transplantation 29: 4-9.
10. Ildstad, S. T., S. M. Wren, J. A. Bluestone, S. A. Barbieri, and D. H. Sachs. 1985. Characterization of mixed allogeneic chimeras: immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J. Exp. Med. 162: 231-244.
11. Metzler, B., P. Gfeller, M. Bigaud, J. Li, G. Wieczorek, C. Heusser, P. Lake, and A. Katopodis. 2004. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection. J. Immunol. 173: 7025-7036.
12. Luo, B., W. F. Chan, A. M. Shapiro, and C. C. Anderson. 2007. Non-myeloablative mixed chimerism approaches and tolerance, a split decision. Eur. J. Immunol. 37: 1233-1242.
13. Boyse, E. A., E. A. Carswell, M. P. Scheid, and L. J. Old. 1973. Tolerance of Sk-incompatible skin grafts. Nature 244: 441-442.
14. Boyse, E. A., E. M. Lance, E. A. Carswell, S. Cooper, and L. J. Old. 1970. Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure. Nature 227: 901-903.
15. Boyse, E. A., and L. J. Old. 1968. Loss of skin allograft tolerance by chimeras. Transplantation 6: 619.
16. Silverman, M. S., and P. H. Chin. 1962. Differences in the rejection of skin transplants and blood cells of donor marrow origin by radiation-induced chimeras. Ann. N Y Acad. Sci. 99: 542-549.
17. Lance, E. M., E. A. Boyse, S. Cooper, and E. A. Carswell. 1971. Rejection of skin allografts by irradiation chimeras: evidence for skin-specific transplantation barrier. Transplant. Proc. 3: 864-868.
18. Steinmuller, D., and J. S. Lofgreen. 1974. Differential survival of skin and heart allografts in radiation chimaeras provides further evidence for Sk histocompatibility antigen. Nature 248: 796-797.
19. Koretz, S. H., M. S. Gottlieb, S. Strober, J. Pennock, C. P. Bieber, R. T. Hoppe, B. A. Reitz, and H. S. Kaplan. 1981. Organ transplantation in mongrel dogs using total lymphoid irradiation (TLI). Transplant. Proc. 13: 443-445.
20. Rose, N. R., R. S. Metzgar, and E. Witebsky. 1960. Studies on organ specificity: XL Isoantigens of rabbit pancreas. J. Immunol. 85: 575-587.
21. Gordon, E. J., L. S. Wicker, L. B. Peterson, D. V. Serreze, T. G. Markees, L. D. Shultz, A. A. Rossini, D. L. Greiner, and J. P. Mordes. 2005. Autoimmune diabetes and resistance to xenograft transplantation tolerance in NOD mice. Diabetes 54: 107-115.
22. Pearson, T., T. G. Markees, D. V. Serreze, M. A. Pierce, M. P. Marron, L. S. Wicker, L. B. Peterson, L. D. Shultz, J. P. Mordes, A. A. Rossini, and D. L. Greiner. 2003. Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice. J. Immunol. 171: 185-195.
23. Pearson, T., T. G. Markees, L. S. Wicker, D. V. Serreze, L. B. Peterson, J. P. Mordes, A. A. Rossini, and D. L. Greiner. 2003. NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction. Diabetes 52: 321-326.
24. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29: 1-13.
25. Serreze, D. V., H. D. Chapman, D. S. Varnum, M. S. Hanson, P. C. Reifsnyder, S. D. Richard, S. A. Fleming, E. H. Leiter, and L. D. Shultz. 1996. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD. Ig μ null mice. J. Exp. Med. 184: 2049-2053.
26. Nanji, S. A., W. W. Hancock, B. Luo, C. D. Schur, R. L. Pawlick, L. F. Zhu, C. C. Anderson, and A. M. Shapiro. 2006. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes 55: 27-33.
27. + T cells facilitate induction of chimerism and tolerance without GVHD in autoimmune NOD mice conditioned with anti-CD3 mAb. Blood 105: 2180-2188.
28. Quesenberry, P. J., S. Zhong, H. Wang, and M. Stewart. 2001. Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice. Blood 97: 557-564.
29. Luo, B., S. A. Nanji, C. D. Schur, R. L. Pawlick, C. C. Anderson, and A. M. Shapiro. 2005. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning. Transplantation 80: 370-377.
30. Koulmanda, M., A. Qipo, H. Auchincloss, Jr., and R. N. Smith. 2003. Effects of streptozotocin on autoimmune diabetes in NOD mice. Clin. Exp. Immunol. 134: 210-216.
31. Guo, Z., T. Wu, H. Sozen, Y. Pan, N. Heuss, H. Kalscheuer, D. E. Sutherland, B. R. Blazar, and B. J. Hering. 2003. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice. Transplantation 75: 909-915.
32. Liu, B., J. Hao, Y. Pan, B. Luo, B. Westgard, Y. Heremans, D. E. Sutherland, B. J. Hering, and Z. Guo. 2006. Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion. Am. J. Transplant. 6: 933-946.
33. Kupfer, T. M., M. L. Crawford, K. Pham, and R. G. Gill. 2005. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo. J. Immunol. 175: 2309-2316.
34. Makhlouf, L., A. Yamada, T. Ito, R. Abdi, M. J. Ansari, C. Q. Khuong, H. J. Winn, H. Auchincloss, Jr., and M. H. Sayegh. 2003. Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice. J. Am. Soc. Nephrol. 14: 2168-2175.
35. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA 88: 527-531.
36. Wood, K. J., and S. Sakaguchi. 2003. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3: 199-210.
37. + regulatory T cells contributes to the onset of autoimmune diabetes. Diabetes 57: 113-123.
38. Kishimoto, H., and J. Sprent. 2001. A defect in central tolerance in NOD mice. Nat. Immunol. 2: 1025-1031.
39. Lesage, S., S. B. Hartley, S. Akkaraju, J. Wilson, M. Townsend, and C. C. Goodnow. 2002. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J. Exp. Med. 196: 1175-1188.
40. Zucchelli, S., P. Holler, T. Yamagata, M. Roy, C. Benoist, and D. Mathis. 2005. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 22: 385-396.
41. Beilhack, G. F., Y. C. Scheffold, I. L. Weissman, C. Taylor, L. Jerabek, M. J. Burge, M. A. Masek, and J. A. Shizuru. 2003. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 52: 59-68.
42. Li, H., C. L. Kaufman, S. S. Boggs, P. C. Johnson, K. D. Patrene, and S. T. Ildstad. 1996. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J. Immunol. 156: 380-388.
43. Li, H., C. L. Kaufman, and S. T. Ildstad. 1995. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Surgery 118: 192-198.
44. Nikolic, B., Y. Takeuchi, I. Leykin, Y. Fudaba, R. N. Smith, and M. Sykes. 2004. Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes 53: 376-383.
45. Seung, E., N. Iwakoshi, B. A. Woda, T. G. Markees, J. P. Mordes, A. A. Rossini, and D. L. Greiner. 2000. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versushost disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 95: 2175-2182.
46. Wu, T., B. Levay-Young, N. Heuss, H. Sozen, N. Kirchhof, D. E. Sutherland, B. Hering, and Z. Guo. 2002. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Transplantation 74: 22-27.
47. Chilton, P. M., F. Rezzoug, M. Z. Ratajczak, I. Fugier-Vivier, J. Ratajczak, M. Kucia, Y. Huang, M. K. Tanner, and S. T. Ildstad. 2005. Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients. Blood 105: 2189-2197.
48. Colson, Y. L., M. J. Schuchert, and S. T. Ildstad. 2000. The abrogation of allosensitization following the induction of mixed allogeneic chimerism. J. Immunol. 165: 637-644.
49. Serreze, D. V., M. A. Osborne, Y. G. Chen, H. D. Chapman, T. Pearson, M. A. Brehm, and D. L. Greiner. 2006. Partial versus full allogeneic hemopoietic chimerization is a preferential means to inhibit type 1 diabetes as the latter induces generalized immunosuppression. J. Immunol. 177: 6675-6684.
50. Colson, Y. L., H. Xu, Y. Huang, and S. T. Ildstad. 2004. Mixed xenogeneic chimerism induces donor-specific humoral and cellular immune tolerance for cardiac xenografts. J. Immunol. 173: 5827-5834.
51. Williams, M. A., A. B. Adams, M. B. Walsh, N. Shirasugi, T. M. Onami, T. C. Pearson, R. Ahmed, and C. P. Larsen. 2003. Primary and secondary immuno competence in mixed allogeneic chimeras. J. Immunol. 170: 2382-2389.
52. Hansen, T. H., S. E. Cullen, R. Melvold, H. Kohn, L. Flaherty, and D. H. Sachs. 1977. Mutation in a new H-2-associated histocompatibility gene closely linked to H-2D. J. Exp. Med. 145: 1550-1558.
53. k. Transplantation 28: 339-342.
54. Huang, C, H. S. Huang, and J. Klein. 1979. Serology and polymorphism of H-2L-locus encoded antigens. Immunogenetics 9: 173-182.
55. db mutant. Transplant. Proc. 11: 642-646.
56. Ivanyi, P., P. Van Mourik, M. Breuning, and C. J. Melief. 1980. Anti-H-2 antibodies induced by syngeneic immunization. Immuno genetics 10: 319-332.
57. Aksentijevich, I., D. H. Sachs, and M. Sykes. 1992. Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen. Transplantation 53: 1108-1114.
58. Sinclair, N. R. 2001. Fc-signalling in the modulation of immune responses by passive antibody. Scand. J. Immunol. 53: 322-330.
59. Ivanyi, P., C. J. Melief, P. van Mourik, A. Vlug, and P. de Greeve. 1979. Lymphocytotoxic antibodies produced by H-2 allo-immunisation distinguish between MuLV-positive and -negative substrains of the same H-2 haplotype. Nature 282: 843-845.
60. Li, Y., L. Ma, J. Shen, and A. S. Chong. 2007. Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc. Natl. Acad. Sci. USA 104: 12093-12098.
61. Shapiro, A., J. Lakey, E. Ryan, G. Korbutt, E. Toth, G. Warnock, N. Kneteman, and R. Rajotte. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using glucocorticoid-free immunosuppressive regimen. N Engl. J. Med. 343: 230-238.
62. Campbell, P. M., P. A. Senior, A. Salam, K. Labranche, D. L. Bigam, N. M. Kneteman, S. Imes, A. Halpin, E. A. Ryan, and A. M. Shapiro. 2007. High risk of sensitization after failed islet transplantation. Am. J. Transplant. 7: 2311-2317.
63. West, L. J., and K. Tao. 2002. Acceptance of third-party cardiac but not skin allografts induced by neonatal exposure to semi-allogeneic lymphohematopoietic cells. Am. J. Transplant. 2: 733-744.